The Global Epidemiology of Diabetes and Kidney Disease

Cited by (684)

Items 201–300 of 684

1. One or two? Comparison of the cardiorenal effects between combination therapy and monotherapy with SGLT2i or GLP1RA
   Mengqing Zhang, Chu Lin, Xiaoling Cai, Ruoyang Jiao, Shuzhen Bai, Zonglin Li, Fang Lv, Wenjia Yang, Geling Liu, Xiaolin Yang et al. · 2024 · Diabetes Obesity and Metabolism
2. Morality in sugar talk: Presenting blood glucose levels in routine diabetes medical visits
   Roberto E. Montenegro, Gonen Dori‐Hacohen · 2020 · Social Science & Medicine
3. Ameliorative effect of a nano chromium metal–organic framework on experimental diabetic chronic kidney disease
   Saideh Fakharzadeh, Somayeh Kalanaky, Hassan Argani, Simin Dadashzadeh, Peyman Mohammadi Torbati, Mohammad Hassan Nazaran, Abbas Basiri · 2020 · Drug Development Research
4. Interplay of Diabetes Mellitus and End-Stage Renal Disease in Open Revascularization for Chronic Limb-Threatening Ischemia
   Heepeel Chang, Caron R. Rockman, Glenn R. Jacobowitz, Neal S. Cayne, Frank J. Veith, Daniel K. Han, Virendra I. Patel, Andrew R. Kumpfbeck, Karan Garg · 2020 · Annals of Vascular Surgery
5. The SGLT-2 Inhibitors in Personalized Therapy of Diabetes Mellitus Patients
   Mariana Cornelia Tilinca, Robert Aurelian Tiucă, Ioan Ţilea, Andreea Varga · 2021 · Journal of Personalized Medicine
6. Posttranslational modifications in diabetes: Mechanisms and functions
   Ang Hu, Haohong Zou, Bin Chen, Jianing Zhong · 2022 · Reviews in Endocrine and Metabolic Disorders
7. Ensemble of fine‐tuned convolutional neural networks for urine sediment microscopic image classification
   Wenqian Liu, Weihong Li, Weiguo Gong · 2019 · IET Computer Vision
8. Investigation of the antioxidant and hypoglycemiant properties of Alibertia edulis (L.C. Rich.) A.C. Rich. leaves
   Diana Figueiredo de Santana Aquino, Tamaeh Monteiro‐Alfredo, Cláudia Andréa Lima Cardoso, Silvia Cristina Heredia Vieira, Maria do Carmo Vieira, Kely de Picoli Souza, Jaime Amaya‐Farfán, Gessika Cristina Borges Castro Carvalho, Carolina Soares Moura, Priscila Neder Morato · 2020 · Journal of Ethnopharmacology
9. Mapping glucose metabolites in the normal bovine lens: Evaluation and optimisation of a matrix‐assisted laser desorption/ionisation imaging mass spectrometry method
   Ali Zahraei, George Guo, Rebecca D. Perwick, Paul James Donaldson, Nicholas J. Demarais, Angus C. Grey · 2020 · Journal of Mass Spectrometry
10. Dietary protein sources and risk of diabetic nephropathy in women: A case-control study
    Monireh Aziz, Yahya Jalilpiran‬, Mehdi Nekouimehr, Shaahin Fattahi, Pari Mokhtari, Ahmad Jayedi, Mir Saeed Yekaninejad, Khadijeh Mirzaei · 2021 · BMC Endocrine Disorders
11. Gut microbiota in a population highly affected by obesity and type 2 diabetes and susceptibility to COVID-19
    Jaime García-Mena, Karina Corona-Cervantes, Daniel Cuervo-Zanatta, Tizziani Benítez-Guerrero, Juan Manuel Vélez-Ixta, Norma Gabriela Zavala-Torres, Loan Edel Villalobos-Flores, Fernando Hernández-Quiroz, Claudia Perez‐Cruz, Selvasankar Murugesan et al. · 2021 · World Journal of Gastroenterology
12. Chronic Kidney Disease in a Tertiary Care Hospital in Nepal
    Mahesh Raj Sigdel, RR Pradhan · 2024 · Journal of Institute of Medicine Nepal
13. Challenges of Glycemic Control in People With Diabetes and Advanced Kidney Disease and the Potential of Automated Insulin Delivery
    Jean Lu, Petrova Lee, Francesco L. Ierino, Richard J. MacIsaac, Elif Ilhan Ekinci, David Norman O'Neal · 2023 · Journal of Diabetes Science and Technology
14. Residual Renal Risk in Diabetic Nephropathy Despite Contemporary Therapies
    Reinhart Speeckaert, Charlotte Delrue, Marijn M. Speeckaert · 2026 · Journal of Clinical Medicine
15. Diabetic Ketoacidosis in Patients with End-stage Kidney Disease: A Review
    Abdulmajeed Al Sadhan, Elwaleed Elhassan, Abdulrahman Altheaby, Yousef Al‐Saleh, Mahfooz A Farooqui · 2021 · Oman Medical Journal
16. Diabetic Kidney Disease in Post-Transplant Diabetes Mellitus: Causes, Treatment and Outcomes
    Lee‐Moay Lim, Jer‐Ming Chang, Hung‐Tien Kuo · 2023 · Biomedicines
17. A fast and efficient method for screening and evaluation of hypoglycemic ingredients of Traditional Chinese Medicine acting on PTP1B by capillary electrophoresis
    Juan Gao, Zhengjin Jiang, Erwin Adams, Ann Van Schepdael · 2024 · Journal of Pharmaceutical and Biomedical Analysis
18. Isoquercitrin improves diabetes nephropathy by inhibiting the sodium-glucose co-transporter-2 pathway
    Wenjie Zhang, Yongxiang Zhang, Wenshan Lv, Zili Kong, Fang Wang, Yangang Wang · 2024 · Biochemical and Biophysical Research Communications
19. Effect of Bilastine on Diabetic Nephropathy in DBA2/J Mice
    Roberta Verta, Cristina Grange, Maura Gurrieri, Sara Borga, Patrizia Nardini, Monica Argenziano, Corrado Ghé, Roberta Cavalli, Elisa Benetti, Gianluca Miglio et al. · 2019 · International Journal of Molecular Sciences
20. Fraxin represses NF-κB pathway via inhibiting the activation of epidermal growth factor receptor to ameliorate diabetic renal tubulointerstitial fibrosis
    Jingran Zeng, Liyin Liang, Rui Chen, Chuting Li, Linjie Pan, Min Wen, Dongxin Lv, Min Liu, Zhanchi Xu, Heqing Huang · 2023 · European Journal of Pharmacology
21. High‐ and normal‐protein diets improve body composition and glucose control in adults with type 2 diabetes: a randomized trial
    Julianne G. Clina, R. Drew Sayer, Zhaoxing Pan, Caroline W. Cohen, Michael T. McDermott, Victoria A. Catenacci, Holly Roxanna Wyatt, James O. Hill · 2023 · Obesity
22. Evaluation of the efficacy of Abelmoschus manihot (L.) on diabetic nephropathy by analyzing biomarkers in the glomeruli and proximal and distal convoluted tubules of the kidneys
    Hongmei Yu, Mei Wang, Jingshi Yu, Haitao Tang, Qing Rong Xu, Ning Cheng, Xiaoxiao Luo, Yurong Wang, Haitao Ge, Lei Qiang et al. · 2023 · Frontiers in Pharmacology
23. Altered Expression of Long Noncoding and Messenger RNAs in Diabetic Nephropathy following Treatment with Rosiglitazone
    Liwen Zhang, Ying Zhou, Fangfang Zhou, Xialian Yu, Jian Liu, Yunzi Liu, Yufei Zhu, Weiming Wang, Nan Chen · 2020 · BioMed Research International
24. A cross‐sectional study exploring cognitive impairment in kidney failure
    Pauline Nicholas, Theresa Green, Louise Purtell, Ann Bonner · 2021 · Journal of Renal Care
25. Metabolomics analysis reveals the renal protective effect of Panax ginseng C. A. Mey in type 1 diabetic rats
    Xin-Sen Wang, Mingxin Hu, Qingxiang Guan, Lihui Men, Zhongying Liu · 2022 · Chinese Journal of Natural Medicines
26. Cardiovascular and renal outcomes with sodium glucose co-transporter 2 inhibitors in patients with type 2 diabetes mellitus: A system review and network meta-analysis
    Lei Tian, Sinan Ai, Huijuan Zheng, Hanwen Yang, Mengqi Zhou, Jingyi Tang, Weijing Liu, Wenjing Zhao, Yaoxian Wang · 2022 · Frontiers in Pharmacology
27. External validation of the risk prediction model for early diabetic kidney disease in Taiwan population: a retrospective cohort study
    Zhenzhen Sun, Kun Wang, Joshua D. Miller, Xiaodan Yuan, Yau‐Jiunn Lee, Qingqing Lou · 2022 · BMJ Open
28. Discovery of the new alpha-glucosidase inhibitor with therapeutic potential in type 2 diabetes mellitus by a novel high-throughput virtual screening and free energy evaluation
    Siyu Deng, Anqi Li, Yubo Zhang · 2023 · Journal of Molecular Graphics and Modelling
29. Association between neck circumference and diabetes mellitus: a systematic review and meta-analysis
    Dandan Li, Yuxin Zhao, Lifang Zhang, Qiqi You, Qingqing Jiang, Xiaoxv Yin, Shiyi Cao · 2023 · Diabetology & Metabolic Syndrome
30. Role of GLP-1 Receptor Agonist in Diabetic Cardio-renal Disorder: Recent Updates of Clinical and Pre-clinical Evidence
    Sanket Seksaria, Bhaskar Jyoti Dutta, Mandeep Kaur, Ghanshyam Das Gupta, Surendra Haribhau Bodakhe, Amrita Singh · 2023 · Current Diabetes Reviews
31. Diagnosis codes underestimate chronic kidney disease incidence compared with eGFR-based evidence: a retrospective observational study of patients with type 2 diabetes in UK primary care
    Rose Sisk, Rory S. Cameron, Waqas Tahir, Camilla Sammut‐Powell · 2023 · BJGP Open
32. Liver and spleen predominantly mediate calciprotein particle clearance in a rat model of chronic kidney disease
    Lara W. Zeper, Caro Bos, Pieter A. Leermakers, Gerben M. Franssen, René Raavé, Joost G.J. Hoenderop, Jeroen H. F. de Baaij · 2024 · American Journal of Physiology-Renal Physiology
33. Evaluating the incidence of complications among people with diabetes according to age of onset: Findings from the UK Biobank
    Seyedeh Forough Sajjadi, Julian W. Sacre, Bendix Carstensen, Sergio Ruiz Carmona, Jonathan E. Shaw, Dianna J. Magliano · 2024 · Diabetic Medicine
34. LncRNA HOXB3OS improves high glucose-mediated podocyte damage and progression of diabetic kidney disease through enhancing SIRT1 mRNA stability
    Yifei Wang, Zhengyi Pang, Wenfang He, Peiyao Ren, Qiang He, Juan Jin · 2024 · Biomedicine & Pharmacotherapy
35. Empagliflozin attenuates renal damage in diabetic nephropathy by modulating mitochondrial quality control via Prdx3-PINK1 pathway
    Canghui Guo, Tao Zhang, Lingyu Du, Ke Yu, Shengnan Zeng, Min Li, Yanqing Chi, Ying Li · 2025 · Biochemical Pharmacology
36. The analysis of risk factors for diabetic kidney disease progression: a single-centre and cross-sectional experiment in Shanghai
    Wen Liu, Juan Du, Xiaoxu Ge, Xiaohong Jiang, Wenfang Peng, Nan Zhao, Lisha Shen, Lili Xia, Fan Hu, Shan Huang · 2022 · BMJ Open
37. Physical Activity Reduces the Risk of Developing Diabetes and Diabetes Medication Use
    Ángel Manuel Denche-Zamorano, David Manuel Mendoza-Muñoz, My works are correct, but my institutional affiliations are incorrect. Some records link me to Instituto de Arqueología-Mérida, which is not my institution. My correct affiliation is University of Extremadura, Carolina Perez-Corraliza, Juan Manuel Franco-García, Jorge Carlos‐Vivas, Raquel Pastor-Cisneros, María Mendoza-Muñoz · 2022 · Healthcare
38. COVID-19 and Chronic Kidney Disease: A Narrative Review
    Mônica Martins, Rodrigo Bueno de Oliveira · 2023 · COVID
39. Comparison of mid-term clinical outcomes after acute myocardial infarction in diabetic men between living alone and living together
    Akira Otani, Kenichi Sakakura, Kei Yamamoto, Yousuke Taniguchi, Miyuki Ito, Tatsuro Ibe, Hiroshi Wada, Shin‐ichi Momomura, Hideo Fujita · 2019 · Heart and Vessels
40. Long‐term renal outcomes associated with sodium glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus: A systematic review and meta‐analysis
    Xiaodan Zhang, Zhen Zhong, Yanli Li, Wangen Li · 2020 · Diabetes/Metabolism Research and Reviews
41. Vasopressin associated with renal vascular resistance in adults with longstanding type 1 diabetes with and without diabetic kidney disease
    Federica Piani, Trenton Reinicke, Yuliya Lytvyn, Isabella L. Melena, Leif Erik Lovblom, VESTA S. LAI, JOSEPHINE M. TSE, Leslie Cham, Andrej Orszag, Bruce A. Perkins et al. · 2020 · Journal of Diabetes and its Complications
42. A Poisson binomial-based statistical testing framework for comorbidity discovery across electronic health record datasets
    Gordon Lemmon, Sergiusz Wesołowski, Alex Henrie, Martin Tristani‐Firouzi, Mark D. Yandell · 2021 · Nature Computational Science
43. Diabetes-Related Microvascular Complications in Primary Health Care Settings in the West Bank, Palestine
    Mohammad Dweib, Nuha El Sharif · 2023 · Journal of Clinical Medicine
44. Risk Prediction and Management of Chronic Kidney Disease in People Living with Type 2 Diabetes Mellitus
    Ying‐Guat Ooi, Tharsini Sarvanandan, Nicholas Ken Yoong Hee, Quan‐Hziung Lim, Sharmila Sunita Paramasivam, Jeyakantha Ratnasingam, Shireene Ratna Vethakkan, Soo Kun Lim, Lee‐Ling Lim · 2024 · Diabetes & Metabolism Journal
45. Utilization of the corticomedullary difference in magnetic resonance imaging-derived apparent diffusion coefficient for noninvasive assessment of chronic kidney disease in type 2 diabetes
    Suyan Duan, Luhan Geng, Lu Fang, Chen Chen, Ling Jiang, Si Chen, Chengning Zhang, Zhimin Huang, Ming Zeng, Bin Sun et al. · 2024 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
46. Temporal and regional trends in adults with diabetics kidney disease in the US from 1999 to 2020
    Muhammad Bilal Sardar, Sophia Ahmed, Hamza Ashraf, Haider Ashfaq, Zain Ali Nadeem, Muhammad Babar, Arsalan Nadeem · 2024 · Diabetes Research and Clinical Practice
47. AdaBoost ‐powered cloud of things framework for low‐latency, energy‐efficient chronic kidney disease prediction
    Zeena N. Al‐Kateeb, Dhuha Basheer Abdullah · 2024 · Transactions on Emerging Telecommunications Technologies
48. Impact of Chronic Kidney Disease and Gout on End-Stage Renal Disease in Type 2 Diabetes: Population-Based Cohort Study
    Inha Jung, Da Young Lee, Seung Min Chung, So Young Park, Ji Hee Yu, Jun Sung Moon, Ji A Seo, Kyungdo Han, Nan Hee Kim · 2024 · Endocrinology and Metabolism
49. Spexin peptide ameliorates renal injury in diabetic nephropathy rat model via modulation of metabolic, oxidative, inflammatory, and apoptotic dysregulations
    Hadeel Elsherbiny, Sulaiman Mohammed Alnasser, Mohamed Aref, Esraa Elsheikh, Sherein F. El-sayed, Nanees F. El-Malkey, Haifa A. Alqahtani, Abdullah A. A. Alghamdi, MOHAMED ABDO NASSAN, Hanan H. Abd‐Elhafeez et al. · 2025 · Journal of Physiology and Biochemistry
50. Study of serum pentraxin 3 level in patients with diabetic nephropathy
    Alaaeldin Abdelsalam Dawood, Mai A. Kamel, Thoria Ahmed Omar, Ahmed Ahmed Mohammed Agaba · 2020 · The Egyptian Journal of Internal Medicine
51. Occupations associated with diabetes complications: A nationwide-multicenter hospital-based case-control study
    Shoko Nakazawa, Kota Fukai, Yuko Furuya, Noriko Kojimahara, Keika Hoshi, Akihiro Toyota, Masayuki Tatemichi · 2022 · Diabetes Research and Clinical Practice
52. Heart and Kidney Outcomes With Ertugliflozin in People with Non-albuminuric Diabetic Kidney Disease: A post hoc Analysis from the Randomized VERTIS CV Trial
    David Z.I. Cherney, Samuel E. Dagogo-Jack, Francesco Cosentino, Richard E. Pratley, Robert C. Frederich, Mario Maldonado, Chih‐Chin Liu, Christopher Paul Cannon · 2022 · Kidney International Reports
53. The protective mechanism of Dehydromiltirone in diabetic kidney disease is revealed through network pharmacology and experimental validation
    Yanzhe Wang, Yuyuan Liu, Sijia Chen, Fengqin Li, Yue Wu, Xinmiao Xie, Nan Zhang, Chuchu Zeng, Linnan Bai, Mengshi Dai et al. · 2023 · Frontiers in Pharmacology
54. Jabuticaba (Plinia trunciflora(O. Berg) Kausel) improved the lipid profile and immune system and reduced oxidative stress in streptozotocin‐induced diabetic rats
    Caroline Calloni, Luana Soares Martínez, Daniela Franciele Gil, Douglas Machado da Silva, Pauline Fagundes Rosales, Fabiana Agostini, Sidnei Moura E. Silva, Matheus Parmegiani Jahn, Mirian Mendonça Salvador · 2020 · Journal of Food Biochemistry
55. Young adult onset type 2 diabetes versus type 1 diabetes: Progression to and survival on renal replacement therapy
    Timothy L. Middleton, Steven James Chadban, Lynda M. Molyneaux, Mario I D'Souza, Maria Constantino, Dennis K. Yue, Margaret J. McGill, Ted Wu, Stephen Morris Twigg, Jencia Wong · 2021 · Journal of Diabetes and its Complications
56. Neurovascular decoupling measured with quantitative susceptibility mapping is associated with cognitive decline in patients with type 2 diabetes
    Min-Hua Ni, Ze‐Yang Li, Qian Sun, Ying Yu, Yang Yang, Bo Hu, Teng Ma, Hao Xie, Sining Li, Lan-Qiu Tao et al. · 2022 · Cerebral Cortex
57. The association between marital quality and diabetes mellitus: A systematic review
    Mohsen Rastkar, Erfan Jalalifar · 2023 · Health Science Reports
58. Association of abdominal obesity with crossing capillaries in the finger nailfold in type 2 diabetes mellitus
    Maiko Shikama, Nao Sonoda, Akiko Morimoto, Sayaka Suga, Tetsuya Tajima, Junji Kozawa, Norikazu Maeda, Michio Otsuki, Taka‐aki Matsuoka, Iichiro Shimomura et al. · 2021 · Diabetology International
59. CAPTO - A method for understanding problem domains for data science projects
    Luis Enrique Zárate, Bruno Petrocchi, Carlos Dias Maia, Caio Felix, Marco Paulo Soares Gomes · 2023 · Concilium
60. Expression and Clinical Significance of Plasma miR-223 in Patients with Diabetic Nephropathy
    Xingrong Guo, Meiying Huang, Dawei Yang, Zuojie Luo · 2023 · International Journal of Endocrinology
61. The role of metabolic reprogramming in kidney cancer
    Ziyi Chen, Xiaohong Zhang · 2024 · Frontiers in Oncology
62. Targeting histamine in metabolic syndrome: Insights and therapeutic potential
    Yiting Wang, Fude Fang, Xiaojun Liu · 2024 · Life Sciences
63. Screening of Methylglyoxal Fluctuations in the Kidneys of Diabetic Nephropathy Mice Using a Europium(III) Complex-Based Dual-Mode Luminescence Probe
    Deshu Kong, Yundi Huang, Bo Song, Xinyue Zhang, Jingli Yuan · 2025 · Analytical Chemistry
64. Associations of Plasma Glucagon Levels with Estimated Glomerular Filtration Rate, Albuminuria and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus
    Huaxing Huang, Lianglan Shen, Haiyan Huang, Lihua Zhao, Feng Xu, Dongmei Zhang, Xiulin Zhang, Tong Chen, Xueqin Wang, Yan Xie et al. · 2021 · Diabetes & Metabolism Journal
65. FTZ promotes islet β-cell regeneration in T1DM mice via the regulation of nuclear proliferation factors
    Zhong Qin, Jianying Yin, Ke Wang, Xu Chen, Hong Wang, Xuguang Hu, Weixuan Wang, Lexun Wang, Weijian Bei, Jiao Guo · 2023 · Journal of Ethnopharmacology
66. Novel pharmacological interventions for diabetic kidney disease
    Seng Kiong Tan, Jairo A Pinzón-Cortés, Mark Emmanuel Cooper · 2023 · Current Opinion in Nephrology & Hypertension
67. Decreased accuracy of erythrocyte sedimentation rate in diagnosing osteomyelitis in diabetic foot infection patients with severe renal impairment: A retrospective cross-sectional study
    Xin Chen, Yi‐Ting Shen, Yuying Wang, Yang Li, Shuyu Guo, Yue Liang, Xuanyu Wang, Siyuan Zhou, Xiaojie Hu, Kaiwen Ma et al. · 2022 · PLoS ONE
68. Common procedures and conditions leading to inpatient hospital admissions in adults with and without diabetes from 2015 to 2019 in Germany
    Alexander J. Eckert, Andreas Fritsche, Andrea Icks, Erhard G. Siegel, Annabel Sandra Mueller‐Stierlin, Wölfram Karges, Joachim Rosenbauer, Marie Auzanneau, Reinhard Walter Holl · 2023 · Wiener klinische Wochenschrift
69. The SONAR study—is there a future for endothelin receptor antagonists in diabetic kidney disease?
    Avivit Cahn, Simona Cernea, Itamar Raz · 2019 · Annals of Translational Medicine
70. Proteinuric and Non-Proteinuric Diabetic Kidney Disease: Different Presentations of the Same Disease?
    Larissa Fabre, Juliana Figueredo Pedregosa-Miguel, Érika Bevilaqua Rangel · 2024 · Diabetology
71. Trends in prescribing sodium‐glucose cotransporter 2 inhibitors for individuals with type 2 diabetes with and without cardiovascular‐renal disease in South Korea, 2015–2021
    Kyoung Hwa Ha, So–Youn Shin, EunJi Na, Dae Jung Kim · 2024 · Journal of Diabetes Investigation
72. Development and validation of machine learning models for predicting low muscle mass in patients with obesity and diabetes
    Jiaying Ge, Siqi Sun, Jiangping Zeng, Yujie Jing, Huihui Ma, Chunhua Qian, Ran Cui, Shen Qu, Hui Sheng · 2025 · Lipids in Health and Disease
73. Barriers in prescribing antidiabetic medications with cardiovascular benefits: practice, experience, and attitudes of GPs in Croatia
    Tomislav Kurevija, Dunja Šojat, Ines Bilić-Čurčić, Silvija Canecki-Varžić, Ljiljana Trtica Majnarić · 2025 · BMC Family Practice
74. Emerging trends and disparities in cardiovascular, kidney, and diabetes-related mortality: A retrospective analysis of the wide-ranging online data for epidemiologic research database
    Aman Goyal, Humza Saeed, Samia Aziz Sulaiman, Wania Sultan, Momina Riaz Siddiqui, Mah I Kan Changez, Arman Qamar, Sarju Ganatra, Sourbha S. Dani · 2025 · PLoS ONE
75. Three decades of CKD due to diabetes mellitus type 2 in China, with projections of disease burden from 2022 to 2036: a systematic analysis for the Global Burden of Disease Study 2021
    Yujun He, Xiaoyi Wang, Yuping Wu, Li Lu, Minhui Liu, Ru Chen, Jingjing He, Wei Mai, Xiaojun Li · 2025 · Clinical Kidney Journal
76. Integrated multi-omics and bioinformatic methods to reveal the mechanisms of sinomenine against diabetic nephropathy
    Yan Li, Lei Wang, Jimin Zhang, Bojun Xu, Huakui Zhan · 2023 · BMC Complementary Medicine and Therapies
77. A Novel Risk Score Model for the Differential Diagnosis of Type 2 Diabetic Nephropathy: A Multicenter Study
    Zhao, Yuetong, Liu, Lin, Zuo, Li, Zhou, Xianghai, Wang, Song, Gao, Hongwei, Yu, Feng, Zhang, Xiaomei, Wang, Mi, Chen, Ling et al. · 2023 · Journal of Diabetes Research
78. Determinants of diabetic nephropathy among diabetic patients in Ethiopia: Systematic review and meta-analysis
    Abere Woretaw Azagew, Zerko Wako Beko, Chilot Kassa Mekonnen · 2024 · PLoS ONE
79. Efficacy evaluation of Berberis aristata and Silybum marianum fixed dose combination on glycaemic and insulin resistance parameters in adult population: a systematic review and meta-analysis of randomized controlled trials
    Vishal P. Dubey, Jignesh J. Kansagra, Varun P. Sureja, Dharmeshkumar Kheni · 2024 · Future Journal of Pharmaceutical Sciences
80. Predicting the onset of chronic kidney disease (CKD) for diabetic patients with aggregated longitudinal EMR data
    Neda Aminnejad, Michelle Greiver, Huaxiong Huang · 2025 · PLOS Digital Health
81. Latin American Expert Consensus for Comprehensive Management of Type 2 Diabetes from a Metabolic–Cardio–Renal Perspective for the Primary Care Physician
    Roopa Mehta, Daniel Pichel, Chih Hao Chen-Ku, Pablo Miguel Raffaele, Antonio Méndez Durán, Francisco Padilla, José Javier Arango Álvarez, José E Costa Gil, Juan Esteban Gómez‐Mesa, Mariano Anibal Giorgi et al. · 2020 · Diabetes Therapy
82. Global Epidemiology, Health Outcomes, and Treatment Options for Patients With Type 2 Diabetes and Kidney Failure
    Jessica Phillips, Jenny H. C. Chen, Esther M. M. Ooi, Janelle Prunster, Wai H. Lim · 2021 · Frontiers in Clinical Diabetes and Healthcare
83. Prevalence of Diabetes and Hypertension Among King Abdulaziz University Employees: Data From First Aid and Cardiopulmonary Resuscitation Training Program
    Mawya A. Khafaji, Kamal Waheeb Alghalayini, Maram Sait, Rafal Alorri, Tasneem Garoub, Esrra A Alharbi, Talah K Magadmi, Falwah Fatani, Hussain F Jan, Abdulkarim Abbas Jawhari · 2021 · Cureus
84. Metabolic Risk Factors Are Associated with the Disease Severity and Prognosis of Hepatitis B Virus-Related Acute on Chronic Liver Failure
    Lu Chen, Jinjin Dai, Qing Xie, Xiaolin Wang, Wei Cai · 2022 · Gut and Liver
85. Hypertriglyceridemia and Other Risk Factors of Chronic Kidney Disease in Type 2 Diabetes: A Hospital-Based Clinic Population in Greece
    Ilias N. Migdalis, Ioannis Ioannidis, Νικόλαος Παπάνας, Athanasios E. Raptis, Alexios Sotiropoulos, George Dimitriadis, on behalf of the Hellenic Diabetic Nephropathy Study (HDNS) · 2022 · Journal of Clinical Medicine
86. Serum Uromodulin in Children and Adolescents with Type 1 Diabetes Mellitus and Controls: Its Potential Role in Kidney Health
    Ralf Schiel, Mathias Block, Antje Steveling, Günter Stein, Sarah Lücking, Jürgen E. Scherberich · 2022 · Experimental and Clinical Endocrinology & Diabetes
87. MR Assessed Changes of Renal Sinus Fat in Response to Glucose Regulation in West European and South Asian Patients With Type 2 Diabetes
    Ling Lin, Ilona A. Dekkers, Qian Tao, Elisabeth H.M. Paiman, Maurice B. Bizino, Ingrid M. Jazet, Hildo J. Lamb · 2023 · Journal of Magnetic Resonance Imaging
88. Discovery of Novel Digital Biomarkers for Type 2 Diabetic Nephropathy Classification via Integration of Urinary Proteomics and Pathology
    Nicholas Lucarelli, Donghwan Yun, Dohyun Han, Brandon G. Ginley, Kyung Chul Moon, Avi Z. Rosenberg, John E. Tomaszewski, Jarcy Zee, Kuang‐Yu Jen, Seung Seok Han et al. · 2023 · medRxiv
89. The promise of xenotransplantation: a challenge
    Christopher Alan Bobier, Adam Omelianchuk, Daniel J. Hurst · 2024 · Journal of Medical Ethics
90. Diroximel fumarate acts through Nrf2 to attenuate methylglyoxal-induced nociception in mice and decrease ISR activation in DRG neurons
    Muhammad Saad Yousuf, Marisol Mancilla Moreno, Brodie J Woodall, Vikram Thakur, Jiahe Li, Lucy He, Rohita Arjarapu, Danielle Royer, Jennifer Zhang, Munmun Chattopadhyay et al. · 2025 · Diabetes
91. Real-World Effectiveness of Finerenone Added to SGLT2 Inhibitor and GLP-1 Receptor Agonist Therapy in Individuals with Type 2 Diabetes and Chronic Kidney Disease
    Afif Nakhleh, Khaled Khazim, Naim Shehadeh · 2025 · Journal of Clinical Medicine
92. High Incidence of Adverse Outcomes in Haemodialysis Patients with Diabetes with or without Diabetic Foot Syndrome: A 5-Year Observational Study in Lleida, Spain
    Montserrat Dòria, Àngels Betriu, Montserrat Belart, Verónica Rosado, Marta Hernández, Felipe Sarró, Jordi Real, Esmeralda Castelblanco, Linda Roxana Pacheco, Elvira Fernández et al. · 2021 · Journal of Clinical Medicine
93. Promising Therapeutic Strategies Targeting Mitochondria in Kidney Diseases: From Small Molecules to Whole Mitochondria
    Alexis Paulina Jiménez‐Uribe, José Pedraza‐Chaverrí · 2022 · Future Pharmacology
94. Evaluation of the prevalence of the most common psychiatric disorders in patients with type 2 diabetes mellitus using the patient health questionnaire: results of the cross-sectional “DIA2PSI” study
    Angelo Emilio Claro, Clelia Palanza, Marianna Mazza, Andrea Corsello, Alessandro Rizzi, Linda Tartaglione, Chiara de Waure, Giuseppe Marano, Simone Piciollo, Giovanna Elsa Ute Muti Schuenemann et al. · 2022 · Acta Diabetologica
95. The multidimensional prognostic index (MPI) predicts long-term mortality in old type 2 diabetes mellitus patients: a 13-year follow-up study
    Francesco Salis, Efisio Cossu, Antonella Mandas · 2023 · Journal of Endocrinological Investigation
96. Prescribing Patterns for Sodium-Glucose Cotransporter 2 Inhibitors: A Survey of Nephrologists
    Tripti Singh, Tingting Li, Didier A. Mandelbrot, Brad C. Astor, Ali Poyan Mehr · 2023 · Kidney International Reports
97. Synergistic effects of Metformin and Forskolin on oxidative stress induced by diabetes and hepatocellular cancer: An animal study
    Qian Yang, Mohammed Abed Jawad, Abdullah Ali Alzahrani, Zahraa F. Hassan, Ahmed Elawady, Ahmed M. Hjazi, Mehran Naghibi · 2024 · Toxicon
98. Empagliflozin alone and in combination with metformin mitigates diabetes-associated renal complications
    Zahraa J. K. Al-Isawi, Zena S. Madhag · 2024 · Journal of Medicine and Life
99. Rate and risk factors of kidney function decline among South Asians with type 2 diabetes: analysis of the CARRS Trial
    Kavita Kumari Singh, Dimple Kondal, Ram Jagannathan, Mohammed Kumail Ali, Dorairaj Prabhakaran, K.M. Venkat Narayan, Shuchi Anand, Nikhil Tandon · 2024 · BMJ Open Diabetes Research & Care
100. Effects of propolis consumption on blood pressure, lipid profile and glycemic parameters in adults: a GRADE-assessed systematic review and dose–response meta-analysis
     Hossein Bahari, Mostafa Shahraki Jazinaki, Kian Goudarzi, Zahra Namkhah, Shaghayegh Taheri, Haniyeh Golafrouz, Naseh Pahlavani · 2024 · British Journal Of Nutrition